TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production
- PMID: 30410495
- PMCID: PMC6209670
- DOI: 10.3389/fimmu.2018.02479
TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production
Abstract
Tripartite motif-containing 21 (TRIM21) is a regulator of tissue inflammation and pro-inflammatory cytokine production, and has been implicated in negative regulation of IRF3-dependent type I interferon signaling. However, the antiviral activity of TRIM21 varies among diverse viruses and its role on regulation of type I interferon remains inconsistent in different microbial infections. Here, we investigate the potential role for TRIM21 in controlling Coxsackievirus B3 (CVB3) replication and susceptible organ pathology. We found that CVB3 infection up-regulated the expression of TRIM21 in hearts of mice and cardiomyocytes at early phase of infection. Knock-down of TRIM21 resulted in increased viral replication, while overexpression led to increased phosphorylation and dimerization of IRF3, increased IFN-β transcription and reduced viral replication in vitro. We demonstrate that TRIM21 promotes the activation of IRF3 in CVB3-infected cells via interacting with MAVS and catalyzing the K27-linked polyubiquitination of MAVS, thereby enhancing type I interferon signaling. The RING domain of ubiquitin ligase activity and PRY-SPRY domain of TRIM21 are critical for its anti-viral effect. In vivo overexpression of TRIM21 significantly protected mice against viral myocarditis by suppressing CVB3 replication and reducing cardiac inflammatory cytokine production. While TRIM21 deficient mice exhibited a decreased IFN-β production, an increased cardiac and pancreatic CVB3 replication, and aggravated pancreatic injury as well as myocarditis during acute infection. Thus, our results demonstrate TRIM21 as a positive regulator of IFN-β signaling by targeting MAVS during CVB3 infection and suggest it as a potent host defense against CVB3 infection and viral-induced injury in hearts and pancreas.
Keywords: IFN-β; IRF3; TRIM21; coxsackievirus B3 (CVB3); viral myocarditis.
Figures
Similar articles
-
TRIM21 Promotes Innate Immune Response to RNA Viral Infection through Lys27-Linked Polyubiquitination of MAVS.J Virol. 2018 Jun 29;92(14):e00321-18. doi: 10.1128/JVI.00321-18. Print 2018 Jul 15. J Virol. 2018. PMID: 29743353 Free PMC article.
-
Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.Antiviral Res. 2015 Nov;123:50-61. doi: 10.1016/j.antiviral.2015.09.001. Epub 2015 Sep 2. Antiviral Res. 2015. PMID: 26343012
-
Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.Virol J. 2012 Dec 19;9:312. doi: 10.1186/1743-422X-9-312. Virol J. 2012. PMID: 23249700 Free PMC article.
-
A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact.Cell Physiol Biochem. 2019;53(1):121-140. doi: 10.33594/000000125. Cell Physiol Biochem. 2019. PMID: 31230428 Review.
-
Multiple Roles of TRIM21 in Virus Infection.Int J Mol Sci. 2023 Jan 14;24(2):1683. doi: 10.3390/ijms24021683. Int J Mol Sci. 2023. PMID: 36675197 Free PMC article. Review.
Cited by
-
Major Group-B Enterovirus populations deleted in the noncoding 5' region of genomic RNA modulate activation of the type I interferon pathway in cardiomyocytes and induce myocarditis.PLoS Pathog. 2024 May 2;20(5):e1012125. doi: 10.1371/journal.ppat.1012125. eCollection 2024 May. PLoS Pathog. 2024. PMID: 38696536 Free PMC article.
-
Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense.Front Cell Dev Biol. 2021 Apr 21;9:671067. doi: 10.3389/fcell.2021.671067. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33968942 Free PMC article. Review.
-
Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy.Cancers (Basel). 2024 Sep 12;16(18):3139. doi: 10.3390/cancers16183139. Cancers (Basel). 2024. PMID: 39335111 Free PMC article. Review.
-
TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity.EMBO Rep. 2020 Jan 7;21(1):e47528. doi: 10.15252/embr.201847528. Epub 2019 Dec 4. EMBO Rep. 2020. PMID: 31797533 Free PMC article.
-
TRIM21 aggravates cardiac injury after myocardial infarction by promoting M1 macrophage polarization.Front Immunol. 2022 Nov 10;13:1053171. doi: 10.3389/fimmu.2022.1053171. eCollection 2022. Front Immunol. 2022. PMID: 36439111 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous